Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients

被引:1
作者
Marco Zuin
Gianluca Rigatelli
Claudio Bilato
Francesco Zanon
Giovanni Zuliani
Loris Roncon
机构
[1] University of Ferrara,Department of Translational Medicine
[2] Santa Maria della Misericordia Hospital,Department of Specialistic Medicine, Division of Cardiology
[3] West Vicenza General Hospitals,Division of Cardiology
[4] Rovigo General Hospital,Arrhythmia and Electrophysiology Unit, Department of Cardiology
来源
Journal of Interventional Cardiac Electrophysiology | 2021年 / 62卷
关键词
Atrial fibrillation; COVID-19; Prevalence; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:231 / 238
页数:7
相关论文
共 255 条
[1]  
Iwasaki YK(2011)Atrial fibrillation pathophysiology: implications for management Circulation. 124 2264-2274
[2]  
Nishida K(2020)Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection J Am Coll Cardiol. 76 533-546
[3]  
Kato T(2020)The variety of cardiovascular presentations of COVID-19 Circulation. 141 1930-1936
[4]  
Nattel S(2020)Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis J Infect. 81 e84-e86
[5]  
Lala A(2020)Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis J Cardiovasc Med (Hagerstown). 21 759-764
[6]  
Johnson KW(2021)Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection Heart Rhythm. S1547-5271 00040-0-81
[7]  
Januzzi JL(2021)New onset atrial fibrillation and risk factors in COVID-19 J Electrocardiol. 65 76-823
[8]  
Fried JA(2020)Cardiac complications in patients hospitalised with COVID-19 Eur Heart J Acute Cardiovasc Care. 9 817-560
[9]  
Ramasubbu K(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med. 6 557-634
[10]  
Bhatt R(2003)Measuring inconsistency in meta-analyses BMJ. 327 629-1554.e3